Ionis Pharmaceuticals, Inc. ( IONS ) just released very positive trial data from phase-3 studies in their pipeline drugs, and the share price responded very positively, rising 80% or so since the news broke. This is phenomenal, but itI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe ...

公司药物研发进展 - Ionis Pharmaceuticals公司发布了其管线药物的三期临床试验数据 数据非常积极 [1] - 受此积极消息影响 公司股价大幅上涨约80% [1]